Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Other Non-Current Liabilities (2023 - 2024)

Contineum Therapeutics' Other Non-Current Liabilities history spans 2 years, with the latest figure at $228000.0 for Q1 2024.

  • Quarterly Other Non-Current Liabilities changed N/A to $228000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $228000.0 through Mar 2024, changed N/A year-over-year, with the annual reading at $110000.0 for FY2023, N/A changed from the prior year.
  • Other Non-Current Liabilities came in at $228000.0 for Q1 2024, up from $110000.0 in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $228000.0 in Q1 2024 to a low of $110000.0 in Q4 2023.